Approval · Notice of Compliance 2879 · 1998
ALORA: Notice of Compliance 2879
Issued February 16, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2879
- Date
- February 16, 1998
- Company
- Procter & Gamble Inc.Cincinnati, Ohio, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Estrogen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALORA | 02237259 | — |
| ALORA | 02237260 | — |
| ALORA | 02237261 | — |